The postpartum period is a time when women are vulnerable to depressive disorders, which can be severe and have long-lasting adverse sequelae. In spite of multiple contacts with health care providers, women with postpartum depression often remain unrecognized and untreated. To evaluate the association between estradiol and postpartum depression, we measured serum estradiol concentration and performed an open-label study of physiologic 17beta-estradiol.
Method
Twenty-three women fulfilling ICD-10 criteria for major depression with postpartum onset were consecutively recruited from a psychiatric emergency unit. Serum estradiol concentrations were measured at baseline and weekly during sublingual 17beta-estradiol treatment for 8 weeks. The treatment effect was assessed using a clinician-rated depression symptom scale, the Montgomery-Asberg Depression Rating Scale (MADRS).
Results
At baseline, all patients were severely depressed (mean MADRS total score = 40.7; range, 35-45) and had a low serum estradiol concentration (mean = 79.8 pmol/L; range, 23-140 pmol/L); in 16/23 patients, the concentration was even lower than the threshold value for gonadal failure. During the first week of estradiol treatment, depressive symptoms diminished significantly, resulting in a mean MADRS score of 11.0 (Z = -4.20, p < .001), and serum estradiol concentrations approached those of the follicular phase (mean +/- SD = 342 +/- 141 pmol/L). At the end of the second week of treatment, the MADRS scores were compatible with clinical recovery in 19/23 patients.
Conclusion
This preliminary study shows that depression symptoms may be rapidly reduced in patients with postpartum depression who have documented estradiol deficiency by treatment with 17beta-estradiol and suggests that estradiol can have significance in the pathophysiology of this condition and may be an option in the treatment of women vulnerable to postpartum depression.
PMID 11411813 11411813 DOI 10.4088/jcp.v62n0504 10.4088/jcp.v62n0504
Cite this article
Ahokas, A., Kaukoranta, J., Wahlbeck, K., & Aito, M. (2001). Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. *The Journal of clinical psychiatry*, *62*(5), 332-336. https://doi.org/10.4088/jcp.v62n0504
Ahokas A, Kaukoranta J, Wahlbeck K, Aito M. Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. J Clin Psychiatry. 2001;62(5):332-336. doi:10.4088/jcp.v62n0504
Ahokas, Antti, et al. "Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study." *The Journal of clinical psychiatry*, vol. 62, no. 5, 2001, pp. 332-336.
Newport DJ et al., 2002The Journal of Clinical Psychiatry
The first 3 postpartum months represent a high-risk period for psychiatric illnesses. This article reviews the prevalence and diagnostic criteria for postpartum illnesses, including the "maternal blue...
Postpartum > Mental Health > Postpartum Depression TreatmentPregnancy > Postpartum Care > Pharmacotherapy During Lactation
Llewellyn AM et al., 1997The Journal of clinical psychiatry
Epidemiologic studies demonstrate a twofold higher rate of depression in women than in men. The childbearing years are a time of increased risk for onset of depression in women. Pregnancy, miscarriage...
Pregnancy > Mental Health > Depression During PregnancyPostpartum > Mental Health > Postpartum Depression TreatmentGeneral OB/GYN > Women's Mental Health > Perinatal Mood Disorders
BACKGROUND: Postnatal depression can have long-term adverse consequences for the mother, for the marital relationship, and for the infant's psychological development. Such depressions can be severe an...
Postpartum > Mental Health > Postpartum Depression TreatmentReproductive Endocrinology > Hormone Therapy > Estrogen as AntidepressantResearch Methodology > Study Design > Randomized Double-Blind Placebo-Controlled Trial
Altshuler LL et al., 1998The Journal of Clinical Psychiatry
Because the onset of mood and anxiety disorders often occurs during the childbearing years, many women may be taking psychotropic medications for these disorders when they conceive. These medications ...
Pregnancy > Complications > Psychiatric DisordersPostpartum > Mental Health > Mood and Anxiety DisordersPregnancy > Medication Safety > Psychotropic Drugs